Stay updated on Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedMinor metadata update: the online date changed from Aug 28 to Aug 28 with the removal of “Online ahead of print.” The core citation content remains the same.SummaryDifference0.2%
- Check17 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference1%
- Check25 days agoChange DetectedAdded revision tag v3.1.0 and removed several core drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with the earlier v3.0.2. This indicates a downsizing of content in safety-related areas.SummaryDifference0.2%
- Check39 days agoChange DetectedExpands and clarifies the Phase 3 PsA trial design for upadacitinib (two periods, explicit dosing arms, long-term extension) and updates drug naming from ABT-494 to upadacitinib, while broadening data-sharing details.SummaryDifference7%
- Check46 days agoChange DetectedThe page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference1%
- Check53 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as new MedlinePlus related topics. Notably, the previous version's references to certain locations and topics have been removed.SummaryDifference17%
Stay in the know with updates to Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in Psoriatic Arthritis Clinical Trial page.